ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of May 20, 2026, ZTS trades at $80.12 with a market cap of $32.58B and a P/E ratio of 13.29. ZTS moved +0.87% today. Year to date, ZTS is -37.33%; over the trailing twelve months it is -51.86%. Its 52-week range spans $72.38 to $197.51. Analyst consensus is buy with an average price target of $129.29. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Zoetis Cuts 2026 EPS Guidance, Q1 Miss Sparks 4% Stock Slide: Zoetis reported first-quarter EPS of $0.88 versus consensus of $0.92 and revenue of $1.96 billion against $2.01 billion estimates, sending shares down over 4% intraday. It cut its 2026 adjusted EPS outlook to $4.15–$4.25 from $4.30–$4.40, citing a tougher sales environment.
| Metric | Value |
|---|---|
| Price | $80.12 |
| Market Cap | $32.58B |
| P/E Ratio | 13.29 |
| EPS | $6.04 |
| Dividend Yield | 0.53% |
| 52-Week High | $197.51 |
| 52-Week Low | $72.38 |
| Volume | 5.99M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.51B |
| Net Income | $2.64B |
| Gross Margin | 71.76% |
14 analysts cover ZTS: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $129.29.